CSPC Pharmaceutical Group Limited (CVG) — Free Cash Flow Generation Index
CSPC Pharmaceutical Group Limited (CVG) has a Free Cash Flow Generation Index of 1.12x as of September 2020. Free cash flow of €2.41 Billion represents 1% of operating cash flow (€2.16 Billion). Explore capital reinvestment ratio of CSPC Pharmaceutical Group Limited to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
CSPC Pharmaceutical Group Limited Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for CSPC Pharmaceutical Group Limited across 13 annual periods. For the full cash flow conversion analysis, see CSPC Pharmaceutical Group Limited (CVG) cash flow conversion.
Annual Free Cash Flow Generation for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year Free Cash Flow Generation Index for CSPC Pharmaceutical Group Limited. Check total reinvestment intensity of CSPC Pharmaceutical Group Limited to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | €3.55 Billion | €5.83 Billion | €2.28 Billion | ▲ +48.8% |
| 2024 | 0.41x | €1.86 Billion | €4.53 Billion | €2.68 Billion | ▼ -25.2% |
| 2023 | 0.55x | €2.29 Billion | €4.18 Billion | €1.89 Billion | ▼ -14.9% |
| 2022 | 0.64x | €4.90 Billion | €7.63 Billion | €2.22 Billion | ▲ +3.6% |
| 2021 | 0.62x | €2.88 Billion | €4.64 Billion | €1.41 Billion | ▼ -19.0% |
| 2020 | 0.77x | €5.16 Billion | €6.74 Billion | €1.36 Billion | ▲ +74.5% |
| 2019 | 0.44x | €1.66 Billion | €3.78 Billion | €1.88 Billion | ▼ -2.9% |
| 2018 | 0.45x | €1.72 Billion | €3.80 Billion | €1.67 Billion | ▼ -14.0% |
| 2017 | 0.53x | €1.73 Billion | €3.29 Billion | €1.18 Billion | ▼ -61.5% |
| 2016 | 1.36x | €3.98 Billion | €2.92 Billion | €1.06 Billion | ▲ +0.1% |
| 2015 | 1.36x | €3.06 Billion | €2.25 Billion | €815.69 Million | ▼ -5.8% |
| 2014 | 1.45x | €2.61 Billion | €1.81 Billion | €807.00 Million | ▼ -16.5% |
| 2013 | 1.73x | €1.41 Billion | €814.86 Million | €597.12 Million | — |